Division of Cardiology, Department of Medicine, University of Washington, Seattle, Washington, USA.
Am J Cardiol. 2010 Apr 1;105(7):1010-3. doi: 10.1016/j.amjcard.2009.11.023. Epub 2010 Feb 13.
Screening for coronary artery disease is common practice in the evaluation of liver transplantation candidates. However, it is unclear whether coronary screening influences transplantation eligibility. We sought to determine the association between screening stress myocardial perfusion imaging (MPI) results and the eligibility for liver transplantation. Within a retrospective cohort of liver transplantation candidates referred for screening stress MPI at a single institution from April 1998 to February 2004, we obtained the baseline characteristics, stress MPI results, transplantation eligibility, and transplantation denial criteria by chart review. Of 294 patients (39%) denied transplantation, the denial criteria were multifactorial for 91 (31%) of the candidates. Compared to candidates with low-risk stress MPI results, the odds of being denied transplantation were the same for candidates with intermediate-risk MPI results (odds ratio 0.93, 95% confidence interval 0.45 to 1.82) or high-risk MPI results (odds ratio 1.42, 95% confidence interval 0.54 to 3.73). This lack of association persisted in our analysis with additional stratification of stress MPI results into negative, positive-low-risk, positive-intermediate-risk, and positive-high-risk. In conclusion, the screening stress MPI results were not associated with liver transplantation eligibility. The large number of competing factors considered before transplantation listing and the low proportion of positive stress MPI results suggests that targeting screening to patients deemed otherwise acceptable for transplantation might increase the influence of stress MPI findings on transplantation eligibility.
在评估肝移植候选人时,筛查冠状动脉疾病是常见的做法。然而,目前尚不清楚冠状动脉筛查是否会影响移植的资格。我们旨在确定筛查应激心肌灌注成像(MPI)结果与肝移植资格之间的关系。在单中心回顾性队列中,我们从 1998 年 4 月至 2004 年 2 月对肝移植候选人进行了筛查应激 MPI,通过图表审查获得了基线特征、应激 MPI 结果、移植资格和移植拒绝标准。在 294 名(39%)被拒绝移植的患者中,91 名(31%)患者的拒绝标准是多因素的。与应激 MPI 结果低危的患者相比,应激 MPI 结果中危的患者(比值比 0.93,95%置信区间 0.45 至 1.82)或高危的患者(比值比 1.42,95%置信区间 0.54 至 3.73)被拒绝移植的可能性相同。在我们的分析中,通过将应激 MPI 结果进一步分层为阴性、阳性低危、阳性中危和阳性高危,这种关联仍然存在。总之,筛查应激 MPI 结果与肝移植资格无关。在移植前列入名单之前考虑了大量的竞争因素,以及应激 MPI 阳性结果的比例较低,这表明将筛查目标针对那些被认为适合移植的患者,可能会增加应激 MPI 结果对移植资格的影响。